Axolabs Email Formats
Biotechnology Research • 
Fritz-Hornschuch Straße 9, Kulmbach, Germany • 101-200 Employees
Axolabs Email Formats
Axolabs uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@axolabs.com), used 83.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@axolabs.com | 83.1% |
{first initial}.{last name} | j.doe@axolabs.com | 15.7% |
{first initial} | j@axolabs.com | 1.2% |
Key Contacts at Axolabs
Keith Hermann
Director, Business Intelligence
Kathleen J. Campau
Sr Director Operations & Site Lead
Christian O. A. Reiser
Director Business Development
Gerard Alvarado
Global Director Msat
Bruno Haas
Associate Director Quality Management, Head Of Quality Assurance
Philipp Hadwiger
Managing Director Research
Adeline Espinasse
Therapeutic Manufacturing Associate Director
Ingo Röhl
Managing Director Operations
Lukas Perkams
Associate Director
Jochen Deckert
Associate Director, Head Of Biology
Company overview
| Headquarters | Fritz-Hornschuch Straße 9, Kulmbach, Bayern 95326, DE |
| Phone number | +499221827620 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | CRO, Bioanalytics, Lead Identification, Cdmo, Oligonucleotide Synthesis, Oligonucleotide Therapeutics |
| Founded | 2011 |
| Employees | 101-200 |
| Socials |
About Axolabs
Axolabs specialises in a new class of drugs whose active ingredients are chemically derived from DNA or RNA. They are called oligonucleotide or nucleic acid therapeutics. We use our many years of expertise to help our clients make them a success. Some of these drugs have already been approved and are being used successfully against diseases that were previously untreatable in some cases. New drugs from this class are added every year. Axolabs is part of the LGC Group. Its business unit for nucleic acid therapeutics is combined under the brand name Axolabs. Axolabs operates companies in the following locations: Axolabs, Kulmbach, Germany Axolab Kulmbach GmbH, is the world’s leading custom research organization in the field of nucleic acid therapeutics with a wide range of services. Axolabs Berlin, Berlin, Germany Axolabs Berlin is currently establishing a new site in Berlin for GMP manufacturing of nucleic acid therapeutics. The site will be dedicated to medium to large scale and early to late phase clinical GMP manufacturing of nucleic acid therapeutics. The state-of-the-art facility will deliver integrated analytical and manufacturing solutions. The operational start date is scheduled for 2025. Axolabs Petaluma, Petaluma, California, USA Axolabs operates a cGMP production facility in Petaluma for oligonucleotide compounds for technical, toxicological and preclinical to late-stage clinical trials. Services: bioinformatics, oligonucleotide synthesis, analytics and in vitro / in vivo analysis.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Axolabs has 84 employees across 11 departments.
Departments
Number of employees
Funding Data
Axolabs has never raised funding before.
Axolabs Tech Stack
Discover the technologies and tools that power Axolabs's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
Programming languages
Security
JavaScript libraries
Hosting
Recruitment & staffing
JavaScript libraries
JavaScript libraries
Belgium
Canada
Frequently asked questions
4.8
40,000 users
